Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: Primary Objective • To test the efficacy of Hydroxychloroquine (HCQ) (400 mg orally daily for 3 days then 200 mg orally daily for an additional 11 days, to complete 14 days) to prevent incident SARS-CoV-2 infection, compared to ascorbic acid among contacts of persons with SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnabas, Ruanne V., Brown, Elizabeth, Bershteyn, Anna, Miller, R. Scott, Wener, Mark, Celum, Connie, Wald, Anna, Chu, Helen, Wesche, David, Baeten, Jared M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268961/
https://www.ncbi.nlm.nih.gov/pubmed/32493478
http://dx.doi.org/10.1186/s13063-020-04446-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268961/
https://www.ncbi.nlm.nih.gov/pubmed/32493478
http://dx.doi.org/10.1186/s13063-020-04446-4

Ejemplares similares